Projected Income Statement: CME Group Inc.

Forecast Balance Sheet: CME Group Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 1,710 610 718 402 422 767 1,232 1,058
Change - -64.33% 17.7% -44.01% 4.98% 81.58% 60.63% -14.12%
Announcement Date 10/02/21 09/02/22 08/02/23 14/02/24 12/02/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: CME Group Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 197.5 127.2 89.7 76.4 94 96.34 99.84 99.94
Change - -35.59% -29.48% -14.83% 23.04% 2.49% 3.63% 0.1%
Free Cash Flow (FCF) 1 2,518 2,275 2,966 3,377 3,596 4,117 3,908 4,428
Change - -9.65% 30.38% 13.86% 6.49% 14.47% -5.06% 13.3%
Announcement Date 10/02/21 09/02/22 08/02/23 14/02/24 12/02/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: CME Group Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 66.05% 66.69% 67.31% 67.86% 70.53% 70.7% 71.16% 72.95%
EBIT Margin (%) 63.11% 63.58% 64.62% 65.61% 68.65% 68.99% 68.97% 70.94%
EBT Margin (%) 55.74% 71.94% 69.54% 74.45% 74.08% 82.19% 81.95% 79.75%
Net margin (%) 43.11% 56.22% 52.94% 57.1% 56.79% 57.07% 57.24% 57.46%
FCF margin (%) 51.56% 48.51% 59.1% 60.54% 58.67% 62.99% 57.18% 61.69%
FCF / Net Income (%) 119.61% 86.3% 111.63% 106.02% 103.3% 110.37% 99.89% 107.36%

Profitability

        
ROA 2.41% 1.64% 1.54% 2.1% 2.76% 2.62% 2.5% 2.6%
ROE 9.19% 9.82% 10.55% 11.88% 13.87% 15.04% 14.92% 15.89%

Financial Health

        
Leverage (Debt/EBITDA) 0.53x 0.2x 0.21x 0.11x 0.1x 0.17x 0.25x 0.2x
Debt / Free cash flow 0.68x 0.27x 0.24x 0.12x 0.12x 0.19x 0.32x 0.24x

Capital Intensity

        
CAPEX / Current Assets (%) 4.04% 2.71% 1.79% 1.37% 1.53% 1.47% 1.46% 1.39%
CAPEX / EBITDA (%) 6.12% 4.07% 2.66% 2.02% 2.17% 2.08% 2.05% 1.91%
CAPEX / FCF (%) 7.84% 5.59% 3.02% 2.26% 2.61% 2.34% 2.55% 2.26%

Items per share

        
Cash flow per share 1 7.574 6.693 8.508 - - - - -
Change - -11.63% 27.12% - - - - -
Dividend per Share 1 5.9 6.85 8.5 9.65 12 11.49 10.86 11.27
Change - 16.1% 24.09% 13.53% 24.35% -4.28% -5.41% 3.77%
Book Value Per Share 1 73.5 76.41 74.89 74.38 73.59 77.36 84.26 99.17
Change - 3.96% -1.99% -0.68% -1.06% 5.12% 8.93% 17.69%
EPS 1 5.87 7.29 7.4 8.86 9.67 10.47 10.94 11.68
Change - 24.19% 1.51% 19.73% 9.14% 8.24% 4.53% 6.76%
Nbr of stocks (in thousands) 358,991 359,399 359,728 359,993 360,362 360,359 360,359 360,359
Announcement Date 10/02/21 09/02/22 08/02/23 14/02/24 12/02/25 - - -
1USD
Estimates
2025 *2026 *
P/E ratio 25.7x 24.6x
PBR 3.48x 3.2x
EV / Sales 15x 14.4x
Yield 4.26% 4.03%
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
269.50USD
Average target price
271.59USD
Spread / Average Target
+0.77%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CME Stock
  4. Financials CME Group Inc.